• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Insulet

Barclays is bullish on medtech

May 26, 2021 By Sean Whooley

A Barclays analysis projects that medtech might be on its way to a stretch of “outperformance” even in the wake of the COVID-19 pandemic. According to SeekingAlpha, the report cited eight reasons that make the investment bank bullish on the industry in the coming years, starting with what it calls “robust innovation.” On top of […]

Filed Under: Business/Financial News, Emerging Markets, Featured, Wall Street Beat Tagged With: Abbott, barclays, Baxter, BD, Boston Scientific, Cardiovascular Systems, coronavirus, COVID-19, Dexcom, Edwards Lifesciences, Insulet, MedTech, Medtronic, Stryker, Tandem Diabetes Care, Zimmer Biomet

Insulet sues Roche over diabetes tech patent

May 12, 2021 By Nancy Crotti

Insulet (NSDQ:PODD) is suing Roche Diabetes Care in the U.K., claiming that Roche prematurely began selling tubeless insulin pumps covered by an Insulet patent three years before that patent expires. The trial for the lawsuit, filed in August 2020, began this week in the U.K. High Court. Get the full story on our sister site, Drug Delivery Business […]

Filed Under: Diabetes, Drug-Device Combinations, Legal News, Patent Infringement Tagged With: Insulet, Roche Diabetes Care

Insulet shares down after Q1 miss

May 7, 2021 By Brian Buntz

Insulet (NSDQ:PODD) stock is down today — a day after the wearable insulin delivery system developer posted break-even Q1 results that were lower than analysts’ expectations. The company, however, yesterday evening raised the low end of its revenue guidance range to 16–20%. The range was previously 15–20%. The Acton, Mass.-based company a net loss of […]

Filed Under: Business/Financial News, Diabetes, Drug Pumps, Drug-Device Combinations, Featured, MassDevice Earnings Roundup, Wall Street Beat Tagged With: diabetes, Insulet

Insulet touts results from Omnipod 5 study, expects launch this year

March 22, 2021 By Sean Whooley

Insulet (NSDQ:PODD) touted positive results from the first pivotal trial for its Omnipod 5 automated insulin delivery system. Omnipod 5 is the world’s first tubeless, wearable system designed to continuously adapt insulin delivery based on glucose levels and trends, according to a news release. Acton, Mass.–based Insulet said the device, which has FDA breakthrough device […]

Filed Under: Clinical Trials, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring Tagged With: Insulet

DTW Podcast: CEO Petrovic explains how Insulet is switching people to `Pods

March 14, 2021 By Tom Salemi

Insulet CEO Shacey Petrovic says she didn’t jump immediately at the chance to join the company. In an interview with the DeviceTalks Weekly Podcast, Petrovic, who was serving as CEO of a women’s health company when CEO-Patrick Sullivan, her former boss at Cytyc, called her with an offer to serve as Insulet’s chief commercial officer […]

Filed Under: Device Talks Podcasts, Diabetes, Drug-Device Combinations, Featured, Special Content Tagged With: Abbott, Adaptive Biotechnologies, AdvaMed, Baxter, Boston Scientific, Calumeo, DeviceTalks Weekly, Dexcom, Insulet

Insulet rises on Street-beating Q4 revenues

February 24, 2021 By Sean Whooley

Insulet (NSDQ:PODD) shares rose before the market opened today on fourth-quarter results that beat the consensus revenue forecast. The Acton, Mass.-based wearable insulin delivery system developer posted losses of -$17.1 million, or -26¢ per share, on sales of $246.1 million for the three months ended Dec. 31, 2020, for a bottom-line slide into the red on […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, MassDevice Earnings Roundup, Wall Street Beat Tagged With: Insulet

Insulet surpasses Q3 earnings estimates, raises guidance

November 5, 2020 By Brian Buntz

Insulet (NSDQ:PODD) posted third-quarter results after market close yesterday that beat analysts’ consensus for the company. The Acton, Mass.-based tubeless insulin pump manufacturer announced profits of $11.6 million or $0.17 per share on sales of $234 million for the three months ended September 30, 2020, for a bottom-line gain of 13.5% on sales growth of 21% […]

Filed Under: Diabetes, Wall Street Beat Tagged With: COVID-19, diabetes, Insulet, PODD, Shacey Petrovic

How much is COVID-19 affecting procedure volumes for medtech?

October 22, 2020 By Sean Whooley

UBS Financial Services released a report detailing how it expects medtech procedures to potentially keep dipping during the COVID-19 pandemic. The report highlighted a quicker-than-expected recovery in the second quarter after U.S. hospitals began canceling, delaying and deferring elective procedures in late March as the pandemic took hold. However, UBS still expects third-quarter medical procedures […]

Filed Under: Business/Financial News, Featured, Surgical Tagged With: Baxter, becton dickinson, Boston Scientific, coronavirus, COVID-19, Dexcom, Insulet, Masimo, Medtronic, Senseonics, Stryker, UBS, Zimmer Biomet

MedTech 100 roundup: Another high as stocks tick up

August 10, 2020 By Sean Whooley

For the third consecutive week, stocks in the medtech industry reached heights not yet seen since the COVID-19 pandemic began. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 89.65 points at the end of last week (Aug. 7). Overall, medtech stocks saw a 0.72% increase from […]

Filed Under: Business/Financial News, Diagnostics, Featured, Funding Roundup, Genomics/Molecular Diagnostics, Initial Public Offering (IPO), MassDevice Earnings Roundup, Mergers & Acquisitions, Pharmaceutical, Research & Development, Wall Street Beat Tagged With: 3m, Abiomed, Acutus Medical, becton dickinson, Cardinal Health, CHF Solutions Inc., coronavirus, COVID-19, DeviceTalks Weekly, Dow Jones, Gilead Sciences, Insulet, Johnson and Johnson, Livongo, MedTech 100 Index, Orthofix, Pfizer, ResMed Inc., S&P, Siemens Healthineers, Teladoc, TransEnterix, Varian Medical Systems

Insulet up on Street-beating Q2, raised guidance

August 7, 2020 By Sean Whooley

Insulet (NSDQ:PODD) shares ticked up today on second-quarter results that topped the consensus forecast. The Acton, Mass.-based wearable insulin delivery system developer posted profits of $14.4 million, or 22¢ per share, on sales of $226.3 million for the three months ended June 30, 2020, for a bottom-line gain of nearly ten times as much as last […]

Filed Under: Business/Financial News, Diabetes, Featured, MassDevice Earnings Roundup, Wall Street Beat Tagged With: coronavirus, COVID-19, Insulet

Insulet installs thousands of solar panels at global HQ

June 24, 2020 By Sean Whooley

Insulet (NSDQ:PODD) announced today that its corporate headquarters and manufacturing facility will be powered by solar-based, renewable energy. The Acton, Mass.-based facility is set to turn to the new energy source, beginning this week. The company covered its 58,000 square-foot manufacturing facility with approximately 2,800 solar panels to, during optimal climate conditions, generate enough energy to […]

Filed Under: Business/Financial News, Diabetes, Featured Tagged With: Insulet

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to page 5
  • Go to page 6
  • Interim pages omitted …
  • Go to page 23
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

August 5, 2022
DTW Medtronic's Greg Smith lays out supply chain strategies
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy